Congenica raises $10 mln
Congenica said Feb. 27 that it raised 8 million pounds ($10 million) in a Series B round. Existing investors, Cambridge Innovation Capital plc and Amadeus Capital Partners, participated alongside new investor, Parkwalk Advisors. Congenica, of the U.K., provides clinical genome analysis technology.
27 February 2017•3 mins read
